A clinical study comparing Triphalapippali yogam tablets and Triphala tablets for treating fatty liver caused by metabolic problems.

Effectiveness of Triphalapippali Yogam in metabolic dysfunction associated fatty liver disease - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103388

Enrollment

Registered

2026-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Willing to provide informed consent Willingness to comply with the trial Liver stiffness measurement 7 to 17.5kPa measured by fibroscan.

Exclusion criteria

Exclusion criteria: Chronic liver disease such as liver cirrhosis Uncontrolled diabetes mellitus HBA1C greater than 9 Pregnant and lactating mothers

Design outcomes

Primary

Measure	Time frame
Fibroscan(liver stiffness measurement)Timepoint: 0th and 91st day	—

Secondary

Measure	Time frame
Liver function test Lipid profile Blood pressure Fasting blood sugar HBA1C BMI Insulin resistanceTimepoint: 0th and 91st day	—

Countries

India

Contacts

Public ContactGreeshma M

Government Ayurveda College Thiruvananthapuram

drdeepasathi@hotmail.com9446171568

Outcome results